Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
18.05
+0.12 (0.67%)
Nov 21, 2024, 4:00 PM EST - Market closed
Entrada Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$23.33
Upside
+29.25%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Maintains $25 → $28 | Buy | Maintains | $25 → $28 | +55.12% | Nov 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +10.80% | Nov 6, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $25 | Buy | Reiterates | $25 | +38.50% | Aug 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | -0.28% | Aug 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | -0.28% | Jun 25, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +10.80% | Mar 18, 2024 |
Oppenheimer | Oppenheimer | Buy Initiates $22 | Buy | Initiates | $22 | +21.88% | Jan 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +10.80% | Nov 27, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +38.50% | Sep 22, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +38.50% | Aug 9, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +38.50% | Aug 2, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +38.50% | May 24, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +38.50% | Apr 3, 2023 |
Goldman Sachs | Goldman Sachs | Hold Maintains $13 → $18 | Hold | Maintains | $13 → $18 | -0.28% | Nov 8, 2022 |
Goldman Sachs | Goldman Sachs | Hold Maintains $10 → $13 | Hold | Maintains | $10 → $13 | -27.98% | Aug 16, 2022 |
Goldman Sachs | Goldman Sachs | Hold Maintains $22 → $10 | Hold | Maintains | $22 → $10 | -44.60% | May 24, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.